Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Phase 2 data showed mean weight loss of up to 24.2% at 48 weeks, which, if confirmed in phase 3 trials, would surpass both CagriSema and tirzepatide
Diese Daten sind praeliminar und stammen aus bioinformatischen Analysen, bilden aber die Grundlage fuer weiterfuehrende in-vivo-Studien
It has Phase 3 REDEFINE-1 data showing about 22.7% weight loss at 68 weeks, and an NDA was filed with FDA in December 2025
It helps give me energy and reduces food cravings Felt immediate results I use this along with tirzepeptide, and it has helped maintain my weight and a boost of energy
Pal-GHK (Palmitoyl Tripeptide-1)
US$ 26.26
US$ 27.86
US$ 27.59
US$ 29.69
